SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: puborectalis who wrote (3508)9/18/1997 2:33:00 AM
From: jack velte   of 3991
 
>> Muse will be surplanted by the oral agents in less than ayear according to my urologist friends.(P.S. I've never owned or shorted this stock).Enjoy the ride while it lasts! <<

this is what i've heard too. pfizer has

"Viagra, a breakthrough oral pill therapy for male erectile dysfunction, is anticipated to be filed in the third quarter. Less than 10 percent of the estimated 150 million men worldwide who have some degree of erectile dysfunction currently seek treatment. Pfizer believes Viagra has the potential to become one of its largest-selling
products." [pfizer press release biz.yahoo.com ]

i've heard the problem with this drug is people that take it like it "too much." sounds like a good problem for a product.

on an aside, the talk in this newsgroup reminds me of pyramid schemes. there is a lot more talk about stock prices than the underlying product.

good luck, longs -- i'm short.

-jack
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext